Gerald Quirk

Directeur Financier/CFO chez SYROS PHARMACEUTICALS, INC.

Profil

Gerald E.
Quirk currently works at Syros Pharmaceuticals, Inc., as Director, Chief Financial & Accounting Officer from 2025.
Mr. Quirk also formerly worked at Choate, Hall & Stewart LLP, as Chairman-Life Sciences Group from 2012 to 2015, Genzyme Corp., as Managing Corporate Counsel from 1998 to 2006, Palmer & Dodge LLP, as Associate-Business Law Department, Infinity Pharmaceuticals, Inc., as Secretary, VP-Corporate Affairs & General Counsel from 2009 to 2012, Tokai Pharmaceuticals, Inc., as Executive VP-Business Operations & General Counsel from 2015 to 2016, and Syros Pharmaceuticals, Inc., as Chief Legal & Administrative Officer from 2017 to 2022.
Mr. Quirk received his graduate degree in 1991 from Harvard University, undergraduate degree in 1989 from Swarthmore College, and graduate degree in 1994 from Northeastern University.

Postes actifs de Gerald Quirk

Sociétés	Poste	Début
SYROS PHARMACEUTICALS, INC.	Directeur Financier/CFO	22/11/2024

Anciens postes connus de Gerald Quirk

Sociétés	Poste	Fin
SYROS PHARMACEUTICALS, INC.	Directeur Administratif	01/03/2022
Tokai Pharmaceuticals, Inc.	Conseiller Juridique Général	31/08/2016
Choate, Hall & Stewart LLP	Corporate Officer/Principal	01/05/2015
INFINITY PHARMACEUTICALS, INC.	Investor Relations Contact	01/08/2012
Genzyme Corp.	Corporate Officer/Principal	01/09/2006